|
adult |
20 |
|
coronavirus |
16 |
|
influenza |
16 |
|
humans |
15 |
|
influenza, human - epidemiology - virology |
15 |
|
female |
14 |
|
male |
14 |
|
middle aged |
14 |
|
pandemic |
14 |
|
covid-19 |
13 |
|
hong kong - epidemiology |
13 |
|
rhizopus microsporus |
13 |
|
sars-cov-2 |
13 |
|
species index: fungi |
13 |
|
vaccine |
13 |
|
acute hepatitis |
12 |
|
aged |
12 |
|
bronchiectasis |
12 |
|
case report |
12 |
|
chronic obstructive lung disease |
12 |
|
disease outbreaks |
12 |
|
adolescent |
11 |
|
adaptation |
10 |
|
aged, 80 and over |
10 |
|
child |
10 |
|
child, preschool |
10 |
|
d222g |
10 |
|
d225g |
10 |
|
h1n1 |
10 |
|
hemagglutinin |
10 |
|
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
|
infant |
10 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
|
linker-immunodominant site |
10 |
|
mutation - genetics |
10 |
|
sialic acid |
10 |
|
spike protein |
10 |
|
young adult |
10 |
|
airway organoid |
9 |
|
animal experiment |
9 |
|
animal model |
9 |
|
anti-bacterial agents - pharmacology |
9 |
|
bagg albino mouse |
9 |
|
clinical outcome |
9 |
|
controlled study |
9 |
|
hong kong |
9 |
|
infectivity |
9 |
|
influenza virus |
9 |
|
novel |
9 |
|
proximal differentiation |
9 |
|
a(h3n2) |
8 |
|
age factors |
8 |
|
antibody |
8 |
|
betacoronavirus |
8 |
|
cell line |
8 |
|
china - epidemiology |
8 |
|
clarithromycin |
8 |
|
cross-reactive |
8 |
|
disease outbreaks - statistics & numerical data |
8 |
|
emc |
8 |
|
feces - virology |
8 |
|
hamster |
8 |
|
hcov-emc |
8 |
|
hku1 |
8 |
|
hospitalized |
8 |
|
incidence |
8 |
|
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
|
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
|
influenza, human - epidemiology - pathology - virology |
8 |
|
naproxen |
8 |
|
neutralization |
8 |
|
oc43 |
8 |
|
oseltamivir |
8 |
|
respiratory system - virology |
8 |
|
reverse transcriptase polymerase chain reaction |
8 |
|
sars |
8 |
|
seasons |
8 |
|
serial |
8 |
|
seroprevalence |
8 |
|
severity of illness index |
8 |
|
stool |
8 |
|
susceptibility |
8 |
|
urine |
8 |
|
urine - virology |
8 |
|
viral load - physiology |
8 |
|
virus cultivation |
8 |
|
virus shedding |
8 |
|
amino acid substitution |
7 |
|
animals |
7 |
|
bacteriological techniques - methods |
7 |
|
chemicals and cas registry numbers |
7 |
|
culture media - chemistry |
7 |
|
diarrhea - epidemiology - microbiology |
7 |
|
hemagglutinins - genetics |
7 |
|
influenza a virus, h1n1 subtype - genetics |
7 |
|
klebsiella infections - epidemiology - microbiology |
7 |
|
klebsiella oxytoca - classification - genetics - isolation and purification - pathogenicity |
7 |
|
antiviral |
6 |
|
elderly |
6 |
|
flavivirus |
6 |
|
gram-positive bacterial infections - epidemiology - microbiology - mortality - physiopathology |
6 |
|
interferon |
6 |
|
meticillin-resistant staphylococcus aureus |
6 |
|
microbial sensitivity tests |
6 |
|
middle east |
6 |
|
molecular modelling |
6 |
|
mortality |
6 |
|
mycophenolic acid |
6 |
|
nosocomial transmission |
6 |
|
novobiocin |
6 |
|
prognosis |
6 |
|
protease |
6 |
|
respiratory |
6 |
|
retrospective studies |
6 |
|
rhinovirus |
6 |
|
ribavirin |
6 |
|
risk factors |
6 |
|
shewanella - classification - drug effects - isolation & purification - pathogenicity |
6 |
|
spa type |
6 |
|
tract |
6 |
|
transmissibility |
6 |
|
transmission dynamics |
6 |
|
treatment |
6 |
|
zika |
6 |
|
actinomycetales - genetics - isolation & purification |
5 |
|
actinomycetales infections - microbiology |
5 |
|
antifungal susceptibility |
5 |
|
antigens, viral - analysis |
5 |
|
arthritis |
5 |
|
arthritis, infectious - microbiology |
5 |
|
bacterial typing techniques |
5 |
|
base sequence |
5 |
|
clostridium difficile |
5 |
|
clostridium difficile - classification - genetics - isolation and purification |
5 |
|
cross infection - prevention and control - transmission - virology |
5 |
|
cytomegalovirus |
5 |
|
disseminated infection recurrence rate |
5 |
|
emerging infectious disease |
5 |
|
enterocolitis, pseudomembranous - epidemiology - microbiology |
5 |
|
h1n1 virus |
5 |
|
hepatitis |
5 |
|
implant |
5 |
|
infection |
5 |
|
infection control - methods |
5 |
|
infection control bundle |
5 |
|
influenza a virus, h1n1 subtype - isolation and purification |
5 |
|
influenza a virus, h3n2 subtype - genetics - isolation and purification |
5 |
|
influenza a virus, h7n9 subtype - genetics - isolation and purification |
5 |
|
influenza, human - diagnosis - virology |
5 |
|
influenza, human - prevention and control - transmission - virology |
5 |
|
kytococcus schroeteri |
5 |
|
molecular identification |
5 |
|
molecular sequence data |
5 |
|
mycobacterium avium complex |
5 |
|
non-aspergillus |
5 |
|
non-dermatophyte |
5 |
|
non-hiv immunosuppression |
5 |
|
nosocomial infection |
5 |
|
onychomycosis |
5 |
|
osteomyelitis |
5 |
|
osteomyelitis - microbiology |
5 |
|
point-of-care systems |
5 |
|
primary prophylaxis |
5 |
|
prosthesis-related infections - microbiology |
5 |
|
ribotype 027 |
5 |
|
ribotyping |
5 |
|
rna virus |
5 |
|
secondary prophylaxis |
5 |
|
seroepidemiological study |
5 |
|
virus evolution |
5 |
|
agar gel electrophoresis |
4 |
|
ancylostoma duodenale |
4 |
|
animals, domestic - microbiology |
4 |
|
anisakis simplex |
4 |
|
antibodies, viral - blood |
4 |
|
antiviral agents - pharmacology |
4 |
|
aortic aneurysm, abdominal - complications - diagnosis - pathology - therapy |
4 |
|
ascaris lumbricoides |
4 |
|
avian |
4 |
|
avian influenza virus |
4 |
|
beta-lactamases - biosynthesis |
4 |
|
blood |
4 |
|
carrier state - microbiology |
4 |
|
cerebrospinal fluid |
4 |
|
clinical |
4 |
|
cloaca - microbiology |
4 |
|
colonization |
4 |
|
coxiella burnetii |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
drug resistance, viral |
4 |
|
endocarditis, bacterial - complications - diagnosis - therapy |
4 |
|
escherichia coli - drug effects - enzymology - isolation & purification |
4 |
|
escherichia coli infections - microbiology |
4 |
|
extended-spectrum β-lactamases |
4 |
|
fungi - isolation and purification |
4 |
|
gordonia |
4 |
|
h10n8 |
4 |
|
h5n1 |
4 |
|
h7n9 |
4 |
|
histopathology |
4 |
|
hongkongensis |
4 |
|
influenza a virus - classification - isolation and purification |
4 |
|
influenza a virus, h1n1 subtype - drug effects |
4 |
|
influenza a virus, h7n9 subtype - immunology - isolation and purification |
4 |
|
influenza in birds - epidemiology - virology |
4 |
|
influenza, human - blood - pathology - virology |
4 |
|
influenza, human - epidemiology - prevention and control - transmission - virology |
4 |
|
middle east respiratory syndrome coronavirus (mers-cov) |
4 |
|
molecular epidemiology |
4 |
|
multiple myeloma - complications - diagnosis - pathology - therapy |
4 |
|
mutation |
4 |
|
nasopharynx - virology |
4 |
|
neuraminidase - antagonists & inhibitors - genetics |
4 |
|
novel coronaviruses |
4 |
|
oseltamivir - pharmacology |
4 |
|
peritoneal dialysis effluent |
4 |
|
phylogeny |
4 |
|
pneumococcal infections - complications - diagnosis - pathology - therapy |
4 |
|
poultry |
4 |
|
q fever |
4 |
|
q fever - diagnosis - epidemiology |
4 |
|
rectum - microbiology |
4 |
|
rodentia - microbiology |
4 |
|
severe acute respiratory syndrome coronavirus (sars-cov) |
4 |
|
tickborne diseases |
4 |
|
zoonoses |
4 |
|
avian influenza a h9n2 |
3 |
|
bone marrow transplantation |
3 |
|
bone marrow transplantation - adverse effects |
3 |
|
ebola virus disease |
3 |
|
ebolavirus |
3 |
|
human betacoronavirus 2c emc/2012 |
3 |
|
immunocompromised host |
3 |
|
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
3 |
|
influenza, human - complications - diagnosis - pathology - virology |
3 |
|
middle east respiratory syndrome |
3 |
|
outbreak |
3 |
|
pneumonia |
3 |
|
respiratory insufficiency - diagnosis - etiology |
3 |
|
severe acute respiratory syndrome |
3 |
|
west africa |
3 |
|
nephrotic syndrome |
2 |
|
strongyloides stercoralis |
2 |
|
strongyloidiasis |
2 |
|
alcohol-based hand rub |
1 |
|
alcohols - pharmacology |
1 |
|
caliciviridae infections - epidemiology - prevention & control |
1 |
|
cross infection - epidemiology - prevention & control |
1 |
|
disease outbreaks - prevention & control |
1 |
|
disinfectants - pharmacology |
1 |
|
hand disinfection - methods |
1 |
|
hand hygiene |
1 |
|
norovirus - isolation & purification |
1 |
|
standard and transmission based precautions |
1 |
